SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+3.98%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$741M
AUM Growth
+$741M
(+15%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
21.02%
Top 10 Holdings %
Top 10 Hldgs %
44.76%
Holding
95
New
21
Increased
23
Reduced
18
Closed
26
Top Buys
| 1 |
FibroGen
FGEN
|
$21.9M |
| 2 |
Smith & Nephew
SNN
|
$20.5M |
| 3 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$19.3M |
| 4 |
Lantheus
LNTH
|
$15.5M |
| 5 |
CVS Health
CVS
|
$14.2M |
Top Sells
| 1 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$12.7M |
| 2 |
NeoGenomics
NEO
|
$9.19M |
| 3 |
CareDx
CDNA
|
$8.03M |
| 4 |
Cytosorbents Corp
CTSO
|
$6.5M |
| 5 |
C4 Therapeutics
CCCC
|
$6.1M |
Sector Composition
| 1 | Healthcare | 95.46% |
| 2 | Financials | 0.86% |
| 3 | Consumer Staples | 0% |
| 4 | Real Estate | 0% |
